Omar Ford
Omar Ford is MD+DI's managing editor. You can reach him at [email protected].
GI Dynamics’ 2nd Chance at an EndoBarrier Pivotal Trial
The company has had significant struggles with the EndoBarrier in the past, but a nod from FDA and the IRB to begin a new pivotal trial might be step back in the right direction for the technology.
Is J&J Becoming a Surgical Robotics Powerhouse?
In addition to J&J picking up Auris Health for $3.4 billion, Roger Smith, Phd, who follows the surgical robotics market closely, said we could continue to see large medtech companies making acquisitions in the space.
Edwards Set to Acquire Cas Medical Systems for $100M
The two companies worked together to develop a smart cable and software module, which would enable compatibility between the FORE-SIGHT sensor and the HemoSphere platform.
Nuvaira Raises $79M for COPD Treatment Device
The Minneapolis-based company was formerly known as Holaira and raised $42 million in 2014.
Can This Wirelessly Charging Heart Pump Reshape the LVAD Market?
The Fully Implanted Ventricular Assist Device was developed using technologies from Jarvik Heart and Leviticus Cardio.
Verily Forges Rehabilitation Center to Fight Opioid Crisis
The company said technology could not solve the opioid epidemic alone and described the One Fifteen solution as a “learning health system.”
Acutus ‘Uncovers’ AcQMap’s Effectiveness with Trial Data
Acutus Medical originally received a nod from FDA in 2017 and a CE mark in 2016 for the AcQMap cardiac imaging technology.
Weighing in on the AI Renaissance in Medtech
Anthony Chang, MD, said he believes that artificial intelligence is going to have a stronger impact in medtech in the coming years, and spoke about the growing trend, at a panel session on the opening day of MD&M West.
Will AI Play a Large Role for Edwards in 2019?
Edwards might be primarily known for its TAVR systems, but the company has been making some interesting forays into the artificial intelligence realm.
GammaTile Therapy Gives Brain Tumor Patients Another Option
The Tempe, AZ-based company has raised $10M in a series A to help further commercialize the Gamma Tile, surgically targeted radiation therapy for patients with brain tumors.
A New Collaboration Could Be Key in the Early Detection of Lung Cancer
Biodesix and MRM are the latest diagnostic firms to enter into a partnership geared at the early detection of lung cancer.
C2N Launches Trial for Alzheimer’s Detection Test
In addition, the company said it has received a breakthrough device designation for the test, which predicts amyloid PET scan results in patients.
Boston Sci’s BPH Treatment Effective in Preserving Sexual Function After 4 Years
The Marlborough, MA-based company’s device treats benign prostatic hyperplasia, and was obtained when it acquired NxThera for $406 million.
Zimmer Biomet Heats Up Surgical Robotics with New FDA Nod
The Warsaw, IN-based company has received clearance for the ROSA Knee System to be used in robotically-assisted total knee replacement procedures.
Endologix’s CE Mark for Nellix is Suspended
The suspension follows the Irvine, CA-based company’s voluntary recall of the device earlier this month.